Who owns AVTX?
Institutional ownership of Avalo Therapeutics Inc. from Form 13F, Q2 2026
126 institutional managers reported holding Avalo Therapeutics Inc. (AVTX) in Form 13F filings for Q2 2026, with 72,612,619 shares worth $1.3B. The largest reported holder was FMR LLC. Managers that filed both quarters added a net 41,041,214 shares (+131.4%). 55 opened new positions and 27 sold out.
- Funds holding
- 126
- Value held
- $1.3B
- New / sold out
- 55 / 27
- Net shares, same filers
- +131.4%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of AVTX
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| FMR LLC | $94.3M | 7.0% | 5,100,216 | Added |
| BlackRock, Inc. | $80.7M | 6.0% | 4,365,553 | Added |
| Nantahala Capital Management, LLC | $68.8M | 5.1% | 3,724,500 | Added |
| Deep Track Capital, LP | $66.7M | 5.0% | 3,610,000 | New |
| Caligan Partners LP | $58.5M | 4.4% | 3,163,866 | Added |
| TCG Crossover Management, LLC | $55.8M | 4.2% | 3,017,120 | Added |
| Affinity Asset Advisors, LLC | $53.6M | 4.0% | 2,900,000 | Added |
| State Street Corp | $53.4M | 4.0% | 2,889,287 | Added |
| Farallon Capital Management, L.l.c. | $46.2M | 3.4% | 2,498,000 | Added |
| Point72 Asset Management, L.P. | $44.1M | 3.3% | 2,387,026 | Added |
| Avoro Capital Advisors LLC | $43.1M | 3.2% | 2,333,333 | Added |
| Vanguard Capital Management LLC | $41.8M | 3.1% | 2,264,246 | Added |
| BVF Inc | $38.4M | 2.9% | 2,075,545 | Added |
| Bank of America Corp | $35.4M | 2.6% | 1,913,829 | Added |
| Adage Capital Partners GP, L.l.c. | $32.0M | 2.4% | 1,729,000 | Added |
| Soleus Capital Management, L.P. | $30.6M | 2.3% | 1,654,978 | Added |
| Braidwell LP | $30.1M | 2.2% | 1,629,182 | New |
| Price T Rowe Associates Inc | $24.2M | 1.8% | 1,311,715 | New |
| Alliancebernstein L.p. | $23.3M | 1.7% | 1,260,689 | New |
| UBS Group AG | $22.3M | 1.7% | 1,209,059 | Added |
| Logos Global Management LP | $21.3M | 1.6% | 1,150,000 | Added |
| Geode Capital Management, LLC | $20.4M | 1.5% | 1,105,118 | Added |
| Commodore Capital LP | $18.8M | 1.4% | 1,018,319 | Added |
| Ra Capital Management, L.p. | $18.5M | 1.4% | 1,000,000 | Added |
| Goldman Sachs Group Inc | $17.5M | 1.3% | 946,320 | Added |
Share of 13F holdings is each fund's shares as a share of the 72,612,619 AVTX shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- BlackRock, Inc. Added+$74.6M
- Deep Track Capital, LP New+$66.7M
- State Street Corp Added+$52.1M
- Nantahala Capital Management, LLC Added+$46.0M
- TCG Crossover Management, LLC Added+$42.1M
- FMR LLC Added+$41.0M
- Braidwell LP New+$30.1M
- Farallon Capital Management, L.l.c. Added+$29.2M
- Affinity Asset Advisors, LLC Added+$28.8M
- Vanguard Capital Management LLC Added+$28.5M
Biggest sellers in Q2 2026
- T. Rowe Price Investment Management, Inc. Sold out-$32.3M
- RTW Investments, LP Trimmed-$12.6M
- Millennium Management LLC Sold out-$12.5M
- Orbimed Advisors LLC Sold out-$7.1M
- Jennison Associates LLC Sold out-$7.0M
- Kennedy Capital Management LLC Sold out-$5.8M
- DV Trading LLC Sold out-$5.4M
- BNP Paribas Financial Markets Trimmed-$5.3M
- Caption Management, LLC Trimmed-$4.5M
- Stempoint Capital LP Sold out-$4.0M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $909M and sold $128M; 47 added and 15 trimmed.
Schedule 13D and 13G filings on AVTX
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-11-13FARALLON CAPITAL MANAGEMENT, L.L.C. SCHEDULE 13G filed by Avalo Therapeutics Inc.Schedule 13G
- 2026-11-10STATE STREET CORP SCHEDULE 13G filed by Avalo Therapeutics Inc.Schedule 13G
- 2026-08-07STATE STREET CORP SCHEDULE 13G filed by Avalo Therapeutics Inc.Schedule 13G
- 2026-07-27BlackRock, Inc. SCHEDULE 13G filed by BlackRock Inc.Schedule 13G
- 2026-04-01Logos Global Management LP SCHEDULE 13G filed by Avalo Therapeutics Inc.Schedule 13G
- 2026-03-06FMR LLC SCHEDULE 13G filed by Avalo Therapeutics Inc.Schedule 13G
- 2026-02-24MILLENNIUM MANAGEMENT LLC SCHEDULE 13G filed by Avalo Therapeutics Inc.Schedule 13G
- 2026-02-17MILLENNIUM MANAGEMENT LLC SCHEDULE 13G filed by Avalo Therapeutics Inc.Schedule 13G
- 2026-02-10MILLENNIUM MANAGEMENT LLC SCHEDULE 13G filed by Avalo Therapeutics Inc.Schedule 13G
- 2026-02-03MILLENNIUM MANAGEMENT LLC SCHEDULE 13G filed by Avalo Therapeutics Inc.Schedule 13G
Questions about AVTX ownership
- Who owns AVTX stock?
- 126 institutional investment managers reported AVTX positions in their Form 13F filings for Q2 2026, holding 72,612,619 shares worth $1.3B in total. FMR LLC reported the largest position.
- Are funds buying or selling AVTX?
- In Q2 2026, 55 managers opened new AVTX positions, 47 added, 15 trimmed and 27 sold out. Managers that filed in both quarters added a net 41,041,214 shares.
- How current is this AVTX institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to AVTX by CUSIP. Options are left out. AVTX news and filings · AVTX insider trades · Top funds